Hurler syndrome (MPS-IH) is an autosomal recessive mucopolysaccharide storage disorder caused by deficiency of lysosomal alpha-l-iduronidase (IDU) A 16-month-old girl with MPS-IH was conditioned uneventfully with busulfan, cyclophosphamide and one dose of total body irradiation 300 cGY (bu/cy/TBI) for a matched unrelated donor (MUD) bone marrow transplantation (BMT). Broad-spectrum antibiotics were started on day +2 because of fever. Nasopharyngeal (NP) swab prior to conditioning was positive for parainfluenza type 3. On day +9 she developed stridor that was attributed to mucositis. However, a repeat NP swab was again positive for parainfluenza type 3 and ribavirin inhalation treatment was initiated on day +12. On day +15, there was sudden unexplained severe oxygen desaturation followed rapidly by cardiorespiratory arrest. She needed complete cardiopulmonary resuscitation. Fresh blood was noted during intubation. Complete blood count (CBC) and coagulation profiles are summarized in Table 1 . Chest X-ray showed whitening of both lung fields with bilateral diffuse confluent pattern of air spaces. She received blood product support and ventilation in the pediatric intensive-care unit (PICU) and had no further pulmonary hemorrhages (PHs). She engrafted for white cells (defined as ANC count 40.5 Â 10 9 /l) on day +19. She was discharged home on day +40. Donor engraftment was successful based on DNA chimerism studies with a normal level of IDU enzyme up to a follow-up period of 7 years.
Patient 1
A 16-month-old girl with MPS-IH was conditioned uneventfully with busulfan, cyclophosphamide and one dose of total body irradiation 300 cGY (bu/cy/TBI) for a matched unrelated donor (MUD) bone marrow transplantation (BMT). Broad-spectrum antibiotics were started on day +2 because of fever. Nasopharyngeal (NP) swab prior to conditioning was positive for parainfluenza type 3. On day +9 she developed stridor that was attributed to mucositis. However, a repeat NP swab was again positive for parainfluenza type 3 and ribavirin inhalation treatment was initiated on day +12. On day +15, there was sudden unexplained severe oxygen desaturation followed rapidly by cardiorespiratory arrest. She needed complete cardiopulmonary resuscitation. Fresh blood was noted during intubation. Complete blood count (CBC) and coagulation profiles are summarized in Table 1 . Chest X-ray showed whitening of both lung fields with bilateral diffuse confluent pattern of air spaces. She received blood product support and ventilation in the pediatric intensive-care unit (PICU) and had no further pulmonary hemorrhages (PHs). She engrafted for white cells (defined as ANC count 40.5 Â 10 9 /l) on day +19. She was discharged home on day +40. Donor engraftment was successful based on DNA chimerism studies with a normal level of IDU enzyme up to a follow-up period of 7 years.
Patient 2
A 23-month-old boy with MPS-IH was conditioned with the same protocol for a MUD BMT. On day -6, he became febrile and a blood culture from the central line was positive for Staphylococcus aureus. His treatment consisted of antibiotic therapy and removal of the central line. However, he remained persistently febrile until day +19 when he engrafted for white blood cells. The following day, there was sudden oxygen desaturation followed by cardiorespiratory arrest. Resuscitation included intubation at which time blood was again noted in the endotracheal tube. The CBC and coagulation profiles are illustrated in Table 1 and the chest X-ray demonstrated bilateral confluent airspace disease similar to patient 1. He continued to need ventilation support with platelet transfusions to keep the platelet count above 50 000/ml. A second life-threatening PH occurred 5 days after the first bleed while he was still on a ventilator. Ventilation continued for 14 days and he was extubated on day +33. DNA chimerism studies and measurement of IDU in peripheral blood leukocytes subsequently demonstrated graft loss and a second transplant was not performed. He is currently 10 years of age and continues to be followed by our metabolic team. spectrum antibiotics were started because of fever. On day +16, a single fever spike of 38.11C preceded sudden oxygen desaturation and cardiorespiratory arrest. His resuscitation included intubation at which time blood was noted in the endotracheal tube. His CBC and coagulation profiles are summarized in Table 1 . Chest X-ray showed bilateral confluent airspace disease similar to patient 1. Engraftment occurred on day +24 and mechanical ventilation was continued for a total of 10 days with an extra 2 days of continuous positive airway pressure. Chimerism studies on day +33 confirmed donor engraftment. He improved clinically, but just prior to a planned discharge home on day +46 he had a second PH with a cardiorespiratory arrest. The course was complicated by multiple PHs (nine in total), multiorgan failure, graft-versus-host disease (GVHD) of the liver and gastrointestinal tract and thrombotic thrombocytopenic purpura (TTP). A lung biopsy performed on day +53 showed diffuse recent and remote intraalveolar hemorrhage with focal thrombosis and nonspecific reactive cellular atypia of alveolar type II cells. Microbiology from bronchoalveolar lavage and lung biopsy was noncontributory. Treatment included supportive measures and blood products, high dose corticosteroids for GVHD and plasmapheresis for the TTP. Ventilation was continued for 54 days. He stayed in hospital for 7 months in total. At the time of this report, he is 10 months post BMT and still needing recurrent admissions for GVHD or fluid and electrolyte management. His bone marrow engraftment is still successful with 490% donor cells based on DNA chimerism studies and measurement of IDU activity in leukocytes.
Discussion
We have described three children with MPS-IH and severe PH following BMT. PH is rare, but well described following autologous and allogeneic BMT. In one of the large adult reviews (1402 patients) of acute bleeding after BMT, 2.8% had PH. 1 The etiology of PH post BMT is unclear, but is likely to be multifactorial and related to thrombocytopenia, infection, coagulopathy, endothelial vessel injury secondary to the conditioning regimen or radiation effect, vasculitis 2 and GVHD. 3 PH has not been described in MPS-IH. In our institution, approximately 80 allogeneic/autologous transplants in children with cancer or serious hematology/immunology/genetic disorders are performed each year. Since 1994, there have been 15 children with MPS-IH who were transplanted in our institution. The occurrence of PH in three out of 15 suggests that there is an increased risk of PH in such a patient population. The time of the PH, just prior to or following engraftment, suggests that it may be related to engraftment. Patient 2 was engrafted at the time of the bleed. Patients 1 and 3 had the bleed 4 and 8 days, respectively, prior to engraftment. We hypothesize that PH may be related to cytokine generation from donor macrophages in the pulmonary vascular tissue even though full hematopoietic engraftment is not yet evident from the peripheral blood count. Timing of the PH in all three patients did not suggest clustering in a certain year or season since it occurred in August 1995 in patient 1, August 1994 in patient 2 and April 2002 in patient 3. There were no other patients with the same complication at the same time. In addition, in MPS-IH, it is well described that mucopolysaccharide deposition in the upper airway may lead to airway obstruction. [4] [5] [6] Whether the mucopolysaccharide deposits in lung tissue predispose to PH by increasing vascular fragility remains unclear. Peters et al 7 reported the outcome of 54 children with MPS-IH who underwent HLA-genotypically identical sibling or HLA-haploidentical-related donor BMT. In his report, the two leading causes of death were cardiopulmonary arrest or failure and GVHD (six deaths each). Two of the cardiopulmonary arrests occurred during preparative therapy and the remaining deaths were post BMT. It is unclear whether this high incidence (11%) of cardiopulmonary causes of death may be somehow related to a higher incidence of PH in children with MPS-IH who are undergoing BMT. As a practical point, we would like to highlight the difficulty in intubation in MPS-IH because of abnormal anatomy. 8 It is even more difficult when there is diffuse PH with blood obstructing the view of the vocal cords. Moreover, PH has a tendency to reoccur as for patients 2 and 3. Hence, the timing for home discharge post BMT after their first bleed can be a difficult decision. In patient 3, the second PH occurred 1 day prior to a planned discharge home. If this bleed had happened at home, death would have been inevitable. We suggest a high index of suspicion be maintained for PH in children with Hurler syndrome following BMT, particularly around the time of engraftment. All our patients had a platelet count o50 000/ml at the time of PH. Moreover, all our patients, as expected, had a platelet count of o50 000/ml in the days preceding the PH. The lowest platelet count for patient 1 was 10 000/ml 3 days prior to the PH, the lowest platelet count for patient 2 was 8 000/ml 1 day prior to the PH and the lowest platelet count for patient 3 was 16 000/ml 1 day prior to the PH. It would, therefore, be advisable to maintain a platelet count probably above 50 000/ml if possible in the days leading to engraftment and for a few days thereafter, and if PH occurs, aggressive supportive care measures should be instituted with blood products and early intubation and ventilation. 
